Ichor is a mission-critical semiconductor supplier trading as a turnaround “call option”: enormous upside if proprietary components lift margins toward 20%, but binary concentration and execution risk define the downside.
Overview
Ichor Holdings is a specialized semiconductor capital equipment supply-chain company that designs and manufactures **fluid delivery subsystems**—gas and chemical delivery assemblies that function as the “circulatory system” of wafer-fab tools. These products are mission-critical for etch and deposition processes, where ultra-pure gases/chemicals must be delivered with precision and reliability. Ichor operates globally (US, Singapore, Malaysia, Mexico) and is a Tier 1 supplier primarily to **Lam Research and Applied Materials**. Its value proposition is helping OEMs reduce fixed manufacturing burden by outsourcing high-mix, low-volume subsystem design/assembly, allowing OEMs to concentrate on core process technology. As of Jan 2026, Ichor is in a transition after a difficult 2024–2025 downcycle marked by inventory corrections and slower memory recovery. New CEO **Phil Barros** (Nov 2025) is focused on operational discipline, factory consolidation, and margin recovery. The market views Ichor as a **recovery/turnaround play**: shares around ~$20.40 imply skepticism that gross margin can break the historical ~12–16% range. The central debate is whether Ichor’s proprietary component roadmap can structurally lift gross margins toward **~20%** over time—creating significant upside—versus risks from customer concentration, execution missteps, and the struggling IMG diversification segment.